1 |
Almaabdi K, Ahmad Z, Johnson SR. Advanced Autoantibody Testing in Systemic Sclerosis. Diagnostics (Basel) 2023;13. [PMID: 36899995 DOI: 10.3390/diagnostics13050851] [Reference Citation Analysis]
|
2 |
Liu P, Chai J, Dai L, Chen B, Zhao J, Lu M, Zeng L, Xia Z, Mu R. Development of a Diagnostic Model Focusing on Esophageal Dysmotility in Patients with Systemic Sclerosis. Diagnostics (Basel) 2022;12. [PMID: 36553149 DOI: 10.3390/diagnostics12123142] [Reference Citation Analysis]
|
3 |
Li H, Cai H. The relationship between immunosuppressive therapy and clinical isolates for patients diagnosed with dermatomyositis-related interstitial lung diseases. International Immunopharmacology 2022;113:109351. [DOI: 10.1016/j.intimp.2022.109351] [Reference Citation Analysis]
|
4 |
Sun Y, Shao C, Huang H, Chen R, Xu K, Li M, Zhang X, Xu Z. Prognostic Analysis of Pneumocystis Jirovecii Pneumonia in Interstitial Lung Disease Patients: A Retrospective Clinical Study. Diagnostics (Basel) 2022;12. [PMID: 36552932 DOI: 10.3390/diagnostics12122925] [Reference Citation Analysis]
|
5 |
Graef J, Bressem KK, Asbach P, Hamm B, Niehues SM. Changing the Patient's Position: Pitfalls and Benefits for Radiation Dose and Image Quality of Computed Tomography in Polytrauma. Diagnostics (Basel) 2022;12. [PMID: 36359504 DOI: 10.3390/diagnostics12112661] [Reference Citation Analysis]
|
6 |
Enomoto N, Naoi H, Mochizuka Y, Isayama T, Tanaka Y, Fukada A, Aono Y, Katsumata M, Yasui H, Mori K, Karayama M, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Inui N, Nakamura Y, Suda T. Frequency, proportion of PF-ILD, and prognostic factors in patients with acute exacerbation of ILD related to systemic autoimmune diseases. BMC Pulm Med 2022;22:387. [PMID: 36289542 DOI: 10.1186/s12890-022-02197-3] [Reference Citation Analysis]
|
7 |
Koga T, Okamoto M, Satoh M, Fujimoto K, Zaizen Y, Chikasue T, Sumi A, Kaieda S, Matsuo N, Matama G, Nouno T, Tominaga M, Yatera K, Ida H, Hoshino T. Positive Autoantibody Is Associated with Malignancies in Patients with Idiopathic Interstitial Pneumonias. Biomedicines 2022;10:2469. [PMID: 36289730 DOI: 10.3390/biomedicines10102469] [Reference Citation Analysis]
|
8 |
Ruaro B, Pozzan R, Confalonieri P, Tavano S, Hughes M, Matucci Cerinic M, Baratella E, Zanatta E, Lerda S, Geri P, Confalonieri M, Salton F. Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Viewer or Actor? To Treat or Not to Treat? Pharmaceuticals (Basel) 2022;15:1033. [PMID: 36015181 DOI: 10.3390/ph15081033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
9 |
Ruaro B, Confalonieri P, Caforio G, Baratella E, Pozzan R, Tavano S, Bozzi C, Lerda S, Geri P, Biolo M, Cortale M, Confalonieri M, Salton F. Chronic Thromboembolic Pulmonary Hypertension: An Observational Study. Medicina (Kaunas) 2022;58. [PMID: 36013561 DOI: 10.3390/medicina58081094] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
|
10 |
Zhou G, Ren Y, Li J, Yang T, Su N, Zhao L, Wang S, Wang D, Li Y, Tian Z, Liu R, Dai H, Wang C. The associations of radiological features of high-resolution computed tomography with the outcomes of transbronchial cryobiopsy in interstitial lung diseases: A cohort study. Front Med 2022;9. [DOI: 10.3389/fmed.2022.959129] [Reference Citation Analysis]
|
11 |
Balmer BD, Blüthgen C, Bässler B, Martini K, Huber FA, Ruby L, Schönenberger A, Frauenfelder T. Influence of CT Image Matrix Size and Kernel Type on the Assessment of HRCT in Patients with SSC-ILD. Diagnostics (Basel) 2022;12. [PMID: 35885565 DOI: 10.3390/diagnostics12071662] [Reference Citation Analysis]
|
12 |
Wang Y, Guo Z, Ma R, Wang J, Wu N, Fan Y, Ye Q. Prognostic Predictive Characteristics in Patients With Fibrosing Interstitial Lung Disease: A Retrospective Cohort Study. Front Pharmacol 2022;13:924754. [DOI: 10.3389/fphar.2022.924754] [Reference Citation Analysis]
|
13 |
Meng K, Tian M, Gui X, Xie M, Gao Y, Shi S, Zhao T, Xiao Y, Cai H, Ding J. Human epididymis protein 4 is associated with severity and poor prognosis of connective tissue disease-associated interstitial lung disease with usual interstitial pneumonia pattern. International Immunopharmacology 2022;108:108704. [DOI: 10.1016/j.intimp.2022.108704] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
14 |
Niu Q, Zhao L, Ma W, Xiong L, Wang X, He X, Yu F. A New Predictive Model for the Prognosis of MDA5+ DM-ILD. Front Med 2022;9:908365. [DOI: 10.3389/fmed.2022.908365] [Reference Citation Analysis]
|
15 |
Lee CT, Ventura IB, Phillips EK, Leahy A, Jablonski R, Montner S, Chung JH, Vij R, Adegunsoye A, Strek ME. Interstitial Lung Disease in Firefighters: An Emerging Occupational Hazard. Front Med (Lausanne) 2022;9:864658. [PMID: 35386918 DOI: 10.3389/fmed.2022.864658] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
16 |
Pulito-cueto V, Remuzgo-martínez S, Genre F, Atienza-mateo B, Mora-cuesta VM, Iturbe-fernández D, Lera-gómez L, Rodriguez-carrio J, Prieto-peña D, Portilla V, Blanco R, Corrales A, Gualillo O, Cifrián JM, López-mejías R, González-gay MA. Angiogenic T Cells: Potential Biomarkers for the Early Diagnosis of Interstitial Lung Disease in Autoimmune Diseases? Biomedicines 2022;10:851. [DOI: 10.3390/biomedicines10040851] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
17 |
Manetti M, Rosa I, Fioretto BS, Matucci-Cerinic M, Romano E. Decreased Serum Levels of SIRT1 and SIRT3 Correlate with Severity of Skin and Lung Fibrosis and Peripheral Microvasculopathy in Systemic Sclerosis. J Clin Med 2022;11:1362. [PMID: 35268452 DOI: 10.3390/jcm11051362] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
18 |
Ruaro B, Salton F, Baratella E, Confalonieri P, Geri P, Pozzan R, Torregiani C, Bulla R, Confalonieri M, Matucci-cerinic M, Hughes M. An Overview of Different Techniques for Improving the Treatment of Pulmonary Hypertension Secondary in Systemic Sclerosis Patients. Diagnostics 2022;12:616. [DOI: 10.3390/diagnostics12030616] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
19 |
Orzechowska B, Awsiuk K, Wnuk D, Pabijan J, Stachura T, Soja J, Sładek K, Raczkowska J. Discrimination between NSIP- and IPF-Derived Fibroblasts Based on Multi-Parameter Characterization of Their Growth, Morphology and Physic-Chemical Properties. Int J Mol Sci 2022;23:2162. [PMID: 35216278 DOI: 10.3390/ijms23042162] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
20 |
Lesley Ann Saketkoo, Reuben Escorpizo, Janos Varga, Kevin John Keen, Kim Fligelstone, Surinder S. Birring, Helene Alexanderson, Henrik Pettersson, Humza Ahmad Chaudhry, Janet L. Poole, Malin Regardt, Daphne LeSage, Catherine Sarver, Joseph Lanario, Elisabetta Renzoni, Mary Beth Scholand, Matthew R. Lammi, Otylia Kowal-Bielecka, Oliver Distler, Tracy Frech, Lee Shapiro, Cecilia Varju, Elizabeth R. Volkmann, Elana J. Bernstein, Marjolein Drent, Ogugua Ndili Obi, Karen C. Patterson, Anne-Marie Russell, The Global Fellowship on Rehabilitation and Exercise in Systemic Sclerosis (G-FoRSS). World Health Organization (WHO) International Classification of Functioning, Disability and Health (ICF) Core Set Development for Interstitial Lung Disease. Front Pharmacol 2022;13:979788. [PMID: 36313333 DOI: 10.3389/fphar.2022.979788] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
21 |
Ruaro B, Baratella E, Confalonieri P, Confalonieri M, Vassallo FG, Wade B, Geri P, Pozzan R, Caforio G, Marrocchio C, Cova MA, Salton F. High-Resolution Computed Tomography and Lung Ultrasound in Patients with Systemic Sclerosis: Which One to Choose? Diagnostics (Basel) 2021;11:2293. [PMID: 34943531 DOI: 10.3390/diagnostics11122293] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|